A study from Turkey: Can tigecycline be an alternative agent in the treatment of brucellosis?

This study is conducted in Van, and aimed to identify the Brucella strains from the collected clinical samples of the patients with brucellosis in Western Anatolia region, and look for tigecycline and azithromycin sensitivity in order to define alternative treatment regimens to the convencional drugs. The 75 isolates included in the study are identified by both conventional and molecular methods and antibiotic sensitivity is determined by E-test. As a result; the drugs used in the treatment brucellosis such as doxycycline, rifampin, streptomycin and ciprofloxacin is found to be effective. Tigecycline is found to be used as an alternative agent in the treatment of brucellosis, while azithromycin is not found to be an appropriate.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753419/

Haber : Dr. Aslıhan Demirel

Posted September 11, 2013